Analytical and Bioanalytical Chemistry

, Volume 396, Issue 7, pp 2449–2459 | Cite as

Analysis of ketamine and norketamine in hair samples using molecularly imprinted solid-phase extraction (MISPE) and liquid chromatography–tandem mass spectrometry (LC-MS/MS)

  • Norlida Harun
  • Robert A. Anderson
  • Peter A. G. Cormack
Original Paper
First Online:
Received:
Revised:
Accepted:

Abstract

An anti-ketamine molecularly imprinted polymer (MIP) was synthesized and used as the sorbent in a solid-phase extraction protocol to isolate ketamine and norketamine from human hair extracts prior to LC-MS/MS analysis. Under optimised conditions, the MIP was capable of selectively rebinding ketamine, a licensed anaesthetic that is widely misused as a recreational drug, with an apparent binding capacity of 0.13 μg ketamine per mg polymer. The limit of detection (LOD) and lower limit of quantification (LLOQ) for both ketamine and norketamine were 0.1 ng/mg hair and 0.2 ng/mg hair, respectively, when 10 mg hair were analysed. The method was linear from 0.1 to 10 ng/mg hair, with correlation coefficients (R 2) of better than 0.99 for both ketamine and norketamine. Recoveries from hair samples spiked with ketamine and norketamine at a concentration of 50 ng/mg were 86% and 88%, respectively. The method showed good intra- and interday precisions (<5%) for both analytes. Minimal matrix effects were observed during the LC-MS/MS analysis of ketamine (ion suppression −6.8%) and norketamine (ion enhancement +0.2%). Results for forensic case samples demonstrated that the method successfully detected ketamine and norketamine concentrations in hair samples with analyte concentrations ranging from 0.2 to 5.7 ng/mg and from 0.1 to 1.2 ng/mg, respectively.

Figure

Illustration of the ketamine-imprinted polymer and its recognition sites.

Keywords

MIPs SPE Ketamine Norketamine Hair LC-MS/MS 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgement

This study was supported by a scholarship from the Department of Public Service and The Ministry of Health, Malaysia.

References

  1. 1.
    Ahmed SN, Petchkovsky L (1980) Abuse of ketamine. Br J Psychiatry 137:303CrossRefGoogle Scholar
  2. 2.
    Siegel RK (1978) Phencyclidine and ketamine intoxication: a study of four populations of recreational users. NIDA Res Monogr 21:119–147Google Scholar
  3. 3.
    Rabben T, Skjelbred P, Oye I (1999) Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther 289(2):1060–1066Google Scholar
  4. 4.
    Dalgarno PJ, Shewan D (1996) Illicit use of ketamine in Scotland. J Psychoactive Drugs 28(2):191–199Google Scholar
  5. 5.
    Jansen KL (1993) Non-medical use of ketamine. BMJ 306(6878):601–602Google Scholar
  6. 6.
    EMCDDA (20002) Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. European Monitoring Centre for Drugs and Drugs Addiction. Office for Official Publications of the European Communities, LuxembourgGoogle Scholar
  7. 7.
    Degenhardt L, Dunn M (2008) The epidemiology of GHB and ketamine use in an Australian household survey. Int J Drug Policy 19(4):311–316CrossRefGoogle Scholar
  8. 8.
    Lua AC, Lin HR, Tseng YT, Hu AR, Yeh PC (2003) Profiles of urine samples from participants at rave party in Taiwan: prevalence of ketamine and MDMA abuse. Forensic Sci Int 136(1–3):47–51CrossRefGoogle Scholar
  9. 9.
    Zhao C, Liu Z, Zhao D, Liu Y, Liang J, Tang Y, Liu Z, Zheng J (2004) Drug abuse in China. Ann N Y Acad Sci 1025:439–445Google Scholar
  10. 10.
    Leong HS, Tan NL, Lui CP, Lee TK (2005) Evaluation of ketamine abuse using hair analysis: concentration trends in a Singapore population. J Anal Toxicol 29(5):314–318Google Scholar
  11. 11.
    Harun N, Anderson RA, Miller EI (2009) Validation of an enzyme-linked immunosorbent assay screening method and a liquid chromatography–tandem mass spectrometry confirmation method for the identification and quantification of ketamine and norketamine in urine samples from Malaysia. J Anal Toxicol 33(6):310–321Google Scholar
  12. 12.
    US Department of Justice (2004) Ketamine: intelligence bulletin (Product No. 2004-L0424-007). US Department of Justice, WashingtonGoogle Scholar
  13. 13.
    Jackson ARW, Jackson JM (2008) Forensic science, 2nd edn. Pearson Education, HarlowGoogle Scholar
  14. 14.
    Cooper G, Moeller M, Kronstrand R (2008) Current status of accreditation for drug testing in hair. Forensic Sci Int 176(1):9–12CrossRefGoogle Scholar
  15. 15.
    Wu YH, Lin KL, Chen SC, Chang YZ (2008) Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair. J Chromatogr B 870(2):192–202Google Scholar
  16. 16.
    Lin YH, Lee MR, Lee RJ, Ko WK, Wu SM (2007) Hair analysis for methamphetamine, ketamine, morphine and codeine by cation-selective exhaustive injection and sweeping micellar electrokinetic chromatography. J Chromatogr A 1145(1–2):234–240CrossRefGoogle Scholar
  17. 17.
    Xiang P, Shen M, Zhuo X (2006) Hair analysis for ketamine and its metabolites. Forensic Sci Int 162(1–3):131–134CrossRefGoogle Scholar
  18. 18.
    Gentili S, Cornetta M, Macchia T (2004) Rapid screening procedure based on headspace solid-phase microextraction and gas chromatography for the detection of many recreational drugs in hair. J Chromatogr B 801:289–296CrossRefGoogle Scholar
  19. 19.
    Ariffin MM, Miller EI, Cormack PAG, Anderson RA (2007) Molecularly imprinted solid-phase extraction of diazepam and its metabolites from hair samples. Anal Chem 79(1):256–262CrossRefGoogle Scholar
  20. 20.
    Anderson RA, Ariffin MM, Cormack PAG, Miller EI (2008) Comparison of molecularly imprinted solid-phase extraction (MISPE) with classical solid-phase extraction (SPE) for the detection of benzodiazepines in post-mortem hair samples. Forensic Sci Int 74(1):40–46CrossRefGoogle Scholar
  21. 21.
    Chapuis F, Pichon V, Hennion M-C (2004) Molecularly imprinted polymers: development and applications of new selective solid-phase extraction materials. LG-GC Europe 17:408–417Google Scholar
  22. 22.
    Stevenson D (1999) Molecularly imprinted polymer for solid-phase extraction. Trends Anal Chem 18:154–158CrossRefGoogle Scholar
  23. 23.
    Masqué N, Marcé RM, Borrull F (2001) Molecularly imprinted polymers: new tailor-made materials for selective solid phase extraction. Trends Anal Chem 20:477–486CrossRefGoogle Scholar
  24. 24.
    Vlatakis G, Andersson LI, Muller R, Mosbach K (1993) Drug assay using antibody mimics made by molecular imprinting. Nature 361(6413):645–647CrossRefGoogle Scholar
  25. 25.
    Miller EI, Wylie F, Oliver J (2008) Simultaneous detection and quantification of amphetamines, diazepam and its metabolites, cocaine and its metabolites, and opiates in hair by LC-ESI-MS-MS using single extraction method. J Anal Toxicol 32:457–469Google Scholar
  26. 26.
    Ariffin MM, Anderson RA (2006) LC/MS/MS analysis of quaternary ammonium drugs and herbicides in whole blood. J Chromatogr B 842:91–97CrossRefGoogle Scholar
  27. 27.
    Al-Asmari AI, Anderson RA (2007) Quantification of opioids and their metabolites in autopsy blood by liquid chromatography-tandem mass spectrometry. J Anal Toxicol 1:394–408Google Scholar
  28. 28.
    Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 75(13):3019–3030Google Scholar
  29. 29.
    Navarro-Villoslada F, Vicente BS, Moreno-Bondi MC (2004) Application of multivariate analysis to the screening of molecularly imprinted polymers for bisphenol A. Anal Chim Acta 504:149–162CrossRefGoogle Scholar
  30. 30.
    Song S, Shi X, Li R, Lin Z, Wu A, Zhang D (2008) Extraction of chlorpromazine with a new molecularly imprinted polymer. Process Biochem 43:1209–1214CrossRefGoogle Scholar
  31. 31.
    Zhu Q, Wang L, Wu S, Wasswa J, Gu X, Tang J (2009) Selectivity of molecularly imprinted solid phase extraction for sterol compounds. Food Chem 113(2):608–615CrossRefGoogle Scholar
  32. 32.
    Simon R, Collins ME, Spivak DA (2007) Shape selectivity versus functional group pre-organization in molecularly imprinted polymers. Anal Chim Acta 591(1):7–16CrossRefGoogle Scholar
  33. 33.
    Moller K, Crescenzi C, Nilsson U (2004) Determination of a flame retardant hydrolysis product in human urine by SPE and LC-MS. Comparison of molecularly imprinted solid-phase extraction with a mixed-mode anion exchanger. Anal Bioanal Chem 378(1):197–204CrossRefGoogle Scholar
  34. 34.
    Baggiani C, Giovannoli C, Anfossi L, Tozzi C (2001) Molecularly imprinted solid-phase extraction sorbent for the clean-up of chlorinated phenoxyacids from aqueous samples. J Chromatogr A 938(1–2):35–44CrossRefGoogle Scholar
  35. 35.
    UNODC (2009) Guidance for the validation of analytical methodology and calibration of equipment used for testing of illicit drugs in seized materials and biological specimens (ST/NAR/41). UNODC, ViennaGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Norlida Harun
    • 1
  • Robert A. Anderson
    • 1
  • Peter A. G. Cormack
    • 2
  1. 1.Forensic Medicine and Science, Division of Cancer Sciences and Molecular Pathology, Faculty of MedicineUniversity of GlasgowGlasgowUK
  2. 2.WestCHEM, Department of Pure and Applied Chemistry, Thomas Graham BuildingUniversity of StrathclydeGlasgowUK

Personalised recommendations